Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Thorp Clay Create: Alert

All | News | Filings
Date FiledTypeDescription
05/19/2023 4 Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Exercised 3,750 restricted stock units @ $0
12/21/2022 4 Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Bought 14,000 shares @ $1.019, valued at $14.3k
12/19/2022 4 Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Disposed of 1,406,507 shares @ $0
Acquired 8,522 shares @ $0
12/19/2022 4/A Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Sold 32,873 shares @ $4.43, valued at $145.6k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns: Bought 21,802 shares @ $2.7622, valued at $60.2k
Bought 14,893 shares @ $2.9671, valued at $44.2k
03/28/2022 4 Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns: Bought 3,000 shares @ $7.2014, valued at $21.6k
01/11/2022 4 Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.
Txns: Converted 1,254,335 shares @ $0
Bought 265,000 shares @ $14, valued at $3.7M
Converted 2,552,021 preferred shares @ $0
Converted 926,506 preferred shares @ $0
01/06/2022 3 Thorp Clay (Director) has filed a Form 3 on Vigil Neuroscience, Inc.
08/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/24/2020 4 Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Bought 3,000 shares @ $3.67, valued at $11k
Bought 2,000 shares @ $3.5, valued at $7k
11/18/2020 4 Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Disposed of 52,397 shares @ $0
Acquired 2,144 shares @ $0
Acquired 10,586 shares @ $0
06/19/2020 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Granted 25,000 options to buy @ $2, valued at $50k
06/05/2020 4 Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 16,000 options to buy @ $4.86, valued at $77.8k
11/26/2019 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Granted 1,518,026 shares @ $1.054, valued at $1.6M
07/03/2019 4 Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Sold 2,014 shares @ $14, valued at $28.2k
Sold 180 shares @ $14, valued at $2.5k
Sold 255 shares @ $14, valued at $3.6k
Sold 459 shares @ $14, valued at $6.4k
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/20/2019 4 Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Sold 277 shares @ $14, valued at $3.9k
Sold 25 shares @ $14, valued at $350
Sold 35 shares @ $14, valued at $490
Sold 63 shares @ $14, valued at $882
05/13/2019 4 Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Granted 11,000 options to buy @ $13.23, valued at $145.5k
03/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Bought 8,000 shares @ $1.36, valued at $10.9k
12/06/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Bought 4,000 shares @ $3.13, valued at $12.5k
10/24/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc
Txns: Converted 52,690 shares @ $0
Converted 1,683,420 shares @ $0
Bought 137,513 shares @ $5, valued at $687.6k
Converted 150,612 shares @ $0
Bought 12,487 shares @ $5, valued at $62.4k
Converted 4,846 shares @ $0
Converted 266,481 shares @ $0
Bought 150,000 shares @ $5, valued at $750k
Exercised 19,061 options to buy @ $0.12, valued at $2.3k
Exercised 19,061 preferred shares @ $0.12, valued at $2.3k
Sold 458 preferred shares @ $5, valued at $2.3k
10/17/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
06/21/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Granted 11,250 options to buy @ $10.74, valued at $120.8k
06/01/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 758,290 shares @ $48, valued at $36.4M
Sold 41,710 shares @ $48, valued at $2M
05/23/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 29,005 shares @ $51.1604, valued at $1.5M
Sold 1,595 shares @ $51.0589, valued at $81.4k
Sold 474 shares @ $52.13, valued at $24.7k
Sold 26 shares @ $52.13, valued at $1.4k
Sold 5,592 shares @ $50.8593, valued at $284.4k
Sold 308 shares @ $50.6851, valued at $15.6k
Sold 474 shares @ $50.5, valued at $23.9k
Sold 26 shares @ $50.5, valued at $1.3k
05/21/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Sold 100,000 shares @ $13.03, valued at $1.3M
Sold 61,139 shares @ $13.16, valued at $804.6k
03/23/2018 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Sold 100,000 shares @ $12.27, valued at $1.2M
Sold 33,630 shares @ $12.07, valued at $405.9k
Sold 5,231 shares @ $12.02, valued at $62.9k
12/07/2017 4 Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.
Txns: Sold 15,000 shares @ $6.37, valued at $95.6k
Sold 15,000 shares @ $6.09, valued at $91.4k
Sold 5,000 shares @ $6.13, valued at $30.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy